Stock TVTX TRAVERE THERAPEUTICS, INC.
Add to a list
To use this feature you must be a member
Log inSign up

Revisions Travere Therapeutics, Inc.

Equities

TVTX

US89422G1076

Real-time Estimate Cboe BZX
Other stock markets
 02:26:20 2024-05-14 pm EDT 		5-day change 1st Jan Change
6.55 USD +3.31% Intraday chart for Travere Therapeutics, Inc. -2.67% -26.92%
May. 07 Canaccord Genuity Adjusts Price Target on Travere Therapeutics to $18 From $15, Maintains Buy Rating MT
May. 06 Travere Therapeutics, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024 CI

Turnover - Change in analysts' estimates

Earnings Per Share (EPS) - Change in analysts' estimates

EBIT - Change in analysts' estimates

Dividend / Share (DPS) - Change in analysts' estimates

Cash or Net Debt - Change in analysts' estimates

Turnover

Earnings Per Share (EPS)

EBIT

Dividend / Share (DPS)

Cash or Net Debt

  1. Stock Market
  2. Equities
  3. TVTX Stock
  4. Revisions Travere Therapeutics, Inc.
-40% Limited Time Offer: Our subscriptions help you unlock hidden opportunities.
SIGN UP NOW